Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine
- PMID: 30135242
- DOI: 10.1124/dmd.118.083246
Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine
Abstract
Cell models to investigate intestinal absorption functions, such as those of transporters and metabolic enzymes, are essential for oral drug discovery and development. The purpose of this study was to generate intestinal epithelial cells from human induced pluripotent stem cells (hiPSC-IECs) and then clarify whether the functions of hydrolase and transporters in them reflect oral drug absorption in the small intestine. The hiPSC-IECs showed the transport activities of P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and peptide transporter 1 (PEPT1), revealed by using their probe substrates ([3H]digoxin, sulfasalazine, and [14C]glycylsarcosine), and the metabolic activities of CYP3A4, CES2, and CES1, which were clarified using their probe substrates (midazolam, irinotecan, and temocapril). The intrinsic clearance by hydrolysis of six ester prodrugs into the active form in hiPSC-IECs was correlated with the plasma exposure (Cmax , AUC, and bioavailability) of the active form after oral administration of these prodrugs to rats. Also, the permeability coefficients of 14 drugs, containing two substrates of P-gp (doxorubicin and [3H]digoxin), one substrate of BCRP (sulfasalazine), and 11 nonsubstrates of transporters (ganciclovir, [14C]mannitol, famotidine, sulpiride, atenolol, furosemide, ranitidine, hydrochlorothiazide, acetaminophen, propranolol, and antipyrine) in hiPSC-IECs were correlated with their values of the fraction of intestinal absorption (Fa) in human clinical studies. These findings suggest that hiPSC-IECs would be a useful cell model to investigate the hydrolysis of ester prodrugs and to predict drug absorption in the small intestine.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.
Similar articles
-
Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase-Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.Drug Metab Dispos. 2022 Jan;50(1):17-23. doi: 10.1124/dmd.121.000605. Epub 2021 Oct 20. Drug Metab Dispos. 2022. PMID: 34670778
-
Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.Mol Pharm. 2010 Oct 4;7(5):1596-607. doi: 10.1021/mp100015x. Epub 2010 Aug 4. Mol Pharm. 2010. PMID: 20604570
-
Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.Mol Pharm. 2009 Jan-Feb;6(1):19-28. doi: 10.1021/mp800088f. Mol Pharm. 2009. PMID: 19248230
-
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.Pharm Res. 2006 Aug;23(8):1675-86. doi: 10.1007/s11095-006-9041-2. Pharm Res. 2006. PMID: 16841194 Review.
-
Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.Eur J Pharm Sci. 2000 Nov;12(1):3-12. doi: 10.1016/s0928-0987(00)00178-0. Eur J Pharm Sci. 2000. PMID: 11121729 Review.
Cited by
-
Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders.J Tissue Eng. 2022 May 9;13:20417314221095339. doi: 10.1177/20417314221095339. eCollection 2022 Jan-Dec. J Tissue Eng. 2022. PMID: 35570845 Free PMC article. Review.
-
Recent Advances in the Gastrointestinal Complex in Vitro Model for ADME Studies.Pharmaceutics. 2023 Dec 27;16(1):37. doi: 10.3390/pharmaceutics16010037. Pharmaceutics. 2023. PMID: 38258048 Free PMC article. Review.
-
Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.Pharmacol Res Perspect. 2020 Oct;8(5):e00645. doi: 10.1002/prp2.645. Pharmacol Res Perspect. 2020. PMID: 32851819 Free PMC article.
-
Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells.Int J Mol Sci. 2020 Jul 14;21(14):4964. doi: 10.3390/ijms21144964. Int J Mol Sci. 2020. PMID: 32674311 Free PMC article.
-
Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study.Cells. 2023 Apr 27;12(9):1269. doi: 10.3390/cells12091269. Cells. 2023. PMID: 37174669 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous